搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Edwardsiella ictaluri Glycerol-3-phosphate dehydrogenase [NAD (P)+] CSB-YP512692EJO
CSB-EP512692EJO
CSB-BP512692EJO
CSB-MP512692EJO
CSB-EP512692EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Acetylglutamate kinase (argB) CSB-YP512693EJO
CSB-EP512693EJO
CSB-BP512693EJO
CSB-MP512693EJO
CSB-EP512693EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Probable ubiquinone biosynthesis protein UbiB (ubiB), partial CSB-YP512694EJO1
CSB-EP512694EJO1
CSB-BP512694EJO1
CSB-MP512694EJO1
CSB-EP512694EJO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Transcriptional repressor NrdR (nrdR) CSB-YP512695EJO
CSB-EP512695EJO
CSB-BP512695EJO
CSB-MP512695EJO
CSB-EP512695EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri 7-cyano-7-deazaguanine synthase (queC) CSB-YP512696EJO
CSB-EP512696EJO
CSB-BP512696EJO
CSB-MP512696EJO
CSB-EP512696EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri UPF0757 protein ymgG (ymgG) CSB-YP512697EJO
CSB-EP512697EJO
CSB-BP512697EJO
CSB-MP512697EJO
CSB-EP512697EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Aspartate--ammonia ligase (asnA) CSB-YP512698EJO
CSB-EP512698EJO
CSB-BP512698EJO
CSB-MP512698EJO
CSB-EP512698EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Flagellar transcriptional regulator FlhD (flhD) CSB-YP512699EJO
CSB-EP512699EJO
CSB-BP512699EJO
CSB-MP512699EJO
CSB-EP512699EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Transcriptional regulator slyA (slyA) CSB-YP512700EJO
CSB-EP512700EJO
CSB-BP512700EJO
CSB-MP512700EJO
CSB-EP512700EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Hydroxylamine reductase (hcp), partial CSB-YP512701EJO
CSB-EP512701EJO
CSB-BP512701EJO
CSB-MP512701EJO
CSB-EP512701EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Exodeoxyribonuclease 7 large subunit (xseA) CSB-YP512702EJO
CSB-EP512702EJO
CSB-BP512702EJO
CSB-MP512702EJO
CSB-EP512702EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Co-chaperone protein hscB (hscB) CSB-YP512703EJO
CSB-EP512703EJO
CSB-BP512703EJO
CSB-MP512703EJO
CSB-EP512703EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Ribosomal protein L11 methyltransferase (prmA) CSB-YP512704EJO
CSB-EP512704EJO
CSB-BP512704EJO
CSB-MP512704EJO
CSB-EP512704EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Membrane protein insertase YidC (yidC), partial CSB-YP512705EJO1
CSB-EP512705EJO1
CSB-BP512705EJO1
CSB-MP512705EJO1
CSB-EP512705EJO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri ProP effector (proQ) CSB-YP512706EJO
CSB-EP512706EJO
CSB-BP512706EJO
CSB-MP512706EJO
CSB-EP512706EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Potassium-transporting ATPase A chain (kdpA), partial CSB-YP512707EJO
CSB-EP512707EJO
CSB-BP512707EJO
CSB-MP512707EJO
CSB-EP512707EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Probable Sec-independent protein translocase protein TatE (tatE), partial CSB-YP512708EJO
CSB-EP512708EJO
CSB-BP512708EJO
CSB-MP512708EJO
CSB-EP512708EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Glutamate--cysteine ligase (gshA), partial CSB-YP512709EJO
CSB-EP512709EJO
CSB-BP512709EJO
CSB-MP512709EJO
CSB-EP512709EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri 50S ribosomal protein L30 (rpmD) CSB-YP512710EJO
CSB-EP512710EJO
CSB-BP512710EJO
CSB-MP512710EJO
CSB-EP512710EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri 30S ribosomal protein S3 (rpsC) CSB-YP512711EJO
CSB-EP512711EJO
CSB-BP512711EJO
CSB-MP512711EJO
CSB-EP512711EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>